Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | P30-EPS |
| Trade Name | |
| Synonyms | P30EPS|P30 EPS |
| Drug Descriptions |
P30-EPS is a peptide vaccine that consist of EphA2, survivin and cytomegalovirus matrix protein pp65 linked to tetanus toxoid epitope P30, which may lead to a cytotoxic T-lymphocyte mediated response against EphA2, CMV pp65 and survivin-expressing tumor cells (NCI Drug Dictionary). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C187131 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| P30-EPS | P30-EPS | 0 | 0 |
| P30-EPS + Poly ICLC | P30-EPS Poly ICLC | 0 | 1 |